Assembly Biosciences (ASMB) Income towards Parent Company: 2016-2025
Historic Income towards Parent Company for Assembly Biosciences (ASMB) over the last 9 years, with Sep 2025 value amounting to -$9.2 million.
- Assembly Biosciences' Income towards Parent Company rose 4.34% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.2 million, marking a year-over-year increase of 4.03%. This contributed to the annual value of -$40.2 million for FY2024, which is 34.38% up from last year.
- Per Assembly Biosciences' latest filing, its Income towards Parent Company stood at -$9.2 million for Q3 2025, which was down 4.29% from -$8.8 million recorded in Q2 2025.
- Assembly Biosciences' Income towards Parent Company's 5-year high stood at -$8.8 million during Q1 2025, with a 5-year trough of -$62.8 million in Q4 2021.
- Its 3-year average for Income towards Parent Company is -$11.7 million, with a median of -$9.6 million in 2024.
- In the last 5 years, Assembly Biosciences' Income towards Parent Company tumbled by 461.45% in 2021 and then spiked by 52.10% in 2024.
- Over the past 4 years, Assembly Biosciences' Income towards Parent Company (Quarterly) stood at -$62.8 million in 2021, then reached -$11.0 million in 2023, then grew by 5.72% to -$10.3 million in 2024, then increased by 4.34% to -$9.2 million in 2025.
- Its Income towards Parent Company was -$9.2 million in Q3 2025, compared to -$8.8 million in Q2 2025 and -$8.8 million in Q1 2025.